Lisinopril/hydrochlorothiazide

From WikiProjectMed
Jump to navigation Jump to search

Lisinopril/hydrochlorothiazide
Combination of
LisinoprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Names
Trade namesZestoretic, Prinzide, others
Clinical data
Pregnancy
category
  • US: D (Evidence of risk)
Routes of
use		By mouth
Defined daily dosenot established[1]
External links
AHFS/Drugs.comMultum Consumer Information
MedlinePlusa601070
Legal
Legal status
  • In general: ℞ (Prescription only)
  (verify)

Lisinopril/hydrochlorothiazide, sold under the trade name Zestoretic among others, is a combination of the medications lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic.[2] It is used to treat high blood pressure.[2] Typically, it becomes an option once a person is doing well on the individual components.[3] It is taken by mouth.[2]

Common side effects include dizziness, headache, cough, and feeling tired.[4] Severe side effects may include angioedema and low blood pressure.[4] Use during pregnancy may harm the baby.[4]

The combination was approved for medical use in the United States in 1989.[2] It is on the World Health Organization's List of Essential Medicines.[5] It is available as a generic medication.[3] In the United States the wholesale cost per dose is less than US$0.05 as of 2018.[6] In the United Kingdom it costs the NHS about GB£0.40 per dose as of 2017.[3] In 2017, it was the 44th most commonly prescribed medication in the United States, with more than 16 million prescriptions.[7][8]

Dosage

The defined daily dose is not established.[1]

Society and culture

Cost

In the United States the wholesale cost per dose is less than US$0.05 as of 2018.[6]In the United Kingdom it costs the NHS about GB£0.40 per dose as of 2017.[3] In 2017, it was the 44th most commonly prescribed medication in the United States, with more than 16 million prescriptions.[7][8]

  • Lisinopril/hydrochlorothiazide prescriptions (US)

  • Lisinopril/hydrochlorothiazide costs (US)

References

  1. ↑ 1.0 1.1 "WHOCC - ATC/DDD Index". www.whocc.no. Retrieved 9 September 2020. CS1 maint: discouraged parameter (link)
  2. ↑ 2.0 2.1 2.2 2.3 "Hydrochlorothiazide and lisinopril Uses, Side Effects & Warnings". Drugs.com. Cerner Multum. Retrieved 26 December 2018. CS1 maint: discouraged parameter (link)
  3. ↑ 3.0 3.1 3.2 3.3 British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. 166. ISBN 978-0857112989.
  4. ↑ 4.0 4.1 4.2 "Lisinopril and Hydrochlorothiazide - FDA prescribing information, side effects and uses". Drugs.com. Solco Healthcare LLC.
  5. ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  6. ↑ 6.0 6.1 "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018. CS1 maint: discouraged parameter (link)
  7. ↑ 7.0 7.1 "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
  8. ↑ 8.0 8.1 "Hydrochlorothiazide; Lisinopril - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.

External links

Identifiers:


Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://mdwiki.org/w/index.php?title=Lisinopril/hydrochlorothiazide&oldid=1108183"